Financials
- Market Capitalization 2.06 B
- Employee 647
- Founded 2004
- CEO N/A
- Website www.admabiologics.com
- Headquarter Delaware, United States
- FIGI BBG002NCK5M5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1958 | ATAI AtaiBeckley Inc. - Common Stock | 5.67 USD | +14.08% | +10.96% | +47.66% | +43.54% | 2.09 B USD | ||
| 1968 | ABCL AbCellera Biologics Inc. - Common Shares | 6.74 USD | +3.37% | -8.80% | +28.87% | +69.77% | 2.06 B USD | ||
| 1970 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.98 USD | -0.31% | -0.62% | -0.62% | +33.95% | 2.06 B USD | ||
| 1971 | NUVB Nuvation Bio Inc. Class A Common Stock | 5.90 USD | +2.43% | +6.50% | +15.23% | +174.42% | 2.05 B USD |
Frequently asked questions about ADMA Biologics Inc - Common Stock
What is the ADMA Biologics Inc - Common Stock stock price today?
The current price of ADMA Biologics Inc - Common Stock (ADMA) is 8.87. Over the past 24 hours, the stock has changed by -1.11%. Follow the ADMA chart for real-time price dynamics.
What is the stock ticker of ADMA Biologics Inc - Common Stock?
ADMA Biologics Inc - Common Stock trades under the ticker ADMA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ADMA Biologics Inc - Common Stock stock going up?
ADMA has changed by -1.55% over the last week, +4.97% over the last month, and -50.72% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was ADMA Biologics Inc - Common Stock net income for the last quarter?
ADMA Biologics Inc - Common Stock reported net income of 45.33 M for the last quarter. The previous quarter showed 49.38 M, which means net income changed by -8.20%.
How many employees does ADMA Biologics Inc - Common Stock have?
As of the latest available data, ADMA Biologics Inc - Common Stock has 647 employees. Workforce size can provide additional context about the company's scale and operations.
What is ADMA Biologics Inc - Common Stock EBITDA?
ADMA Biologics Inc - Common Stock EBITDA is 60.07 M, and its EBITDA margin is 52.47%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ADMA Biologics Inc - Common Stock stock?
You can buy ADMA Biologics Inc - Common Stock (ADMA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ADMA Biologics Inc - Common Stock stock?
Investing in ADMA Biologics Inc - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ADMA chart and related analysis on metatrader.com as part of your research.